Cancer Research and Treatment10.4143/crt.2020.0802020523945-956Inhibition of ATR Increases the Sensitivity to WEE1 Inhibitor in Biliary Tract CancerAh-Rong Nam, Mei-Hua Jin, Ju-Hee Bang, Kyoung-Seok Oh, Hye-Rim Seo, Do-Youn Oh, Yung-Jue Bang,,
10.21203/ Inhibitor 4SC-202 Increases Sensitivity to Epirubicin in Liver Cancer Cells by Inhibition of ATMZhixiang Cheng, Quan Sun, Ping Jiang, Bo Liao,
Cancer Letters10.1016/j.canlet.2021.05.029202151638-47ATR inhibition amplifies antitumor effects of olaparib in biliary tract cancerAh-Rong Nam, Jeesun Yoon, Mei-Hua Jin, Ju-Hee Bang, Kyoung-Seok Oh, Hye-Rim Seo, Jae-Min Kim, Tae-Yong Kim, Do-Youn Oh,
Cancers10.3390/cancers13153790202113153790Differential Effects of Combined ATR/WEE1 Inhibition in Cancer CellsGro Elise Rødland, Sissel Hauge, Grete Hasvold, Lilli T. E. Bay, Tine T. H. Raabe, Mrinal Joel, Randi G. Syljuåsen
Cancer Letters10.1016/j.canlet.2016.09.0242016383141-52Inhibition of ATR-dependent feedback activation of Chk1 sensitises cancer cells to Chk1 inhibitor monotherapyAndrew J. Massey,
Cancer Research and Treatment10.4143/crt.2018.52620195131167-1179Therapeutic Targeting of the DNA Damage Response Using an ATR Inhibitor in Biliary Tract CancerAh-Rong Nam, Mei Hua Jin, Ji Eun Park, Ju-Hee Bang, Do-Youn Oh, Yung-Jue Bang,,
Neoplasia10.1016/j.neo.2018.03.0032018205478-488Combined Inhibition of ATR and WEE1 as a Novel Therapeutic Strategy in Triple-Negative Breast CancerJuan Jin, Hehui Fang, Fang Yang, Wenfei Ji, Nan Guan, Zijia Sun, Yaqin Shi, Guohua Zhou, Xiaoxiang Guan,
European Journal of Cancer10.1016/s0959-8049(12)71906-820124834108 Parallel siRNA and Compound Screens to Identify Molecular Determinants of Sensitivity to WEE1 Inhibition in Breast CancerM. Aarts, I. Garcia-Murillas, C. Toniatti, A. Ashworth, N.C. Turner,
Blumgart's Surgery of the Liver, Pancreas and Biliary Tract10.1016/b978-1-4377-1454-8.00108-92012135-141.e1Molecular pathogenesis of biliary tract cancerGeorge Miller,
European Journal of Cancer10.1016/s0959-8049(16)32640-5201669S20Inhibition of BCKDK increases the sensitivity of ovarian cancer cells to paclitaxelM.N. Abed, A. Richardson,